Primum non nocere: Should adults with idiopathic FSGS receive steroids?

Seminars in Nephrology

Volumn 23, Issue 2, 2003, Pages 229-233

  Franceschini, Nora ^a   Hogan, Susan Lynn ^a   Falk, Ronald J ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; CYTOTOXIC AGENT; METHYLPREDNISOLONE; PREDNISOLONE; PREDNISONE;

ABSCESS; ADRENAL SUPPRESSION; ATHEROSCLEROSIS; CATARACT; CUSHING DISEASE; DATA ANALYSIS; DIABETES MELLITUS; DOSE RESPONSE; DRUG EFFICACY; DRUG FATALITY; FOCAL SEGMENTAL GLOMERULOSCLEROSIS; FOLLOW UP; FRACTURE; GASTROINTESTINAL DISEASE; GLOMERULOSCLEROSIS; HEART INFARCTION; HUMAN; HYPERLIPIDEMIA; INFECTION; KAPOSI SARCOMA; KIDNEY BIOPSY; KIDNEY FAILURE; LONG TERM CARE; LUNG CANCER; MYOPATHY; OBESITY; OSTEOLYSIS; OSTEOPOROSIS; PANCREAS CANCER; PNEUMONIA; PRIORITY JOURNAL; PROGNOSIS; REMISSION; REVIEW; STEROID THERAPY; STOMACH HEMORRHAGE; SURVIVAL RATE; TREATMENT OUTCOME; VARICELLA ZOSTER VIRUS; VIRUS INFECTION;

EID: 0037349368     PISSN: 02709295     EISSN: None     Source Type: Journal    
DOI: 10.1053/snep.2003.50021     Document Type: Review

References (26)

1. Pei Y, Cattran D, Delmore T, et al: Evidence suggesting under-treatment in adults with idiopathic focal segmental glomerulosclerosis. Regional Glomerulonephritis Registry Study. Am J Med 82:938-944, 1987
2. Keenan GF: Management of complications of glucocorticoid therapy. Clin Chest Med 18:507-520, 1997
3. Saag KG, Koehnke R, Caldwell JR, et al: Low dose long-term corticosteroid therapy in rheumatoid arthritis: An analysis of serious adverse events. Am J Med 96:115-123, 1994
4. Kalbak K: Incidence of arteriosclerosis in patients with rheumatoid arthritis receiving long-term corticosteroid therapy. Ann Rheum Dis 31:196-200, 1972
5. Korbet SM, Schwartz MM, Lewis EJ: Primary focal segmental glomerulosclerosis: Clinical course and response to therapy. Am J Kidney Dis 23:773-783, 1994
6. Burgess E: Management of focal segmental glomerulosclerosis: Evidence-based recommendations. Kidney Int Suppl 70:S26-S32, 1999
7. Rydel JJ, Korbet SM, Borok RZ, et al: Focal segmental glomerular sclerosis in adults: Presentation, course, and response to treatment. Am J Kidney Dis 25:534-542, 1995
8. Agarwal SK, Dash SC, Tiwari SC, et al: Idiopathic adult focal segmental glomerulosclerosis: A clinicopathological study and response to steroid. Nephron 63:168-171, 1993
9. Cattran DC, Rao P: Long-term outcome in children and adults with classic focal segmental glomerulosclerosis. Am J Kidney Dis 32:72-79, 1998
10. Ponticelli C, Villa M, Banfi G, et al: Can prolonged treatment improve the prognosis in adults with focal segmental glomerulosclerosis? Am J Kidney Dis 34:618-625, 1999
11. Chitalia VC, Wells JE, Robson RA, et al: Predicting renal survival in primary focal glomerulosclerosis from the time of presentation. Kidney Int 56:2236-2242, 1999
12. Meyrier A: Treatment of primary focal segmental glomerulosclerosis. Nephrol Dial Transplant 14:74-78, 1999 (suppl 3)
13. Howie AJ, Brewer DB: The glomerular tip lesion: A previously undescribed type of segmental glomerular abnormality. J Pathol 142:205-220, 1984
14. Howie AJ, Brewer DB: Further studies on the glomerular tip lesion: Early and late stages and life table analysis. J Pathol 147:245-255, 1985
15. Hogan-Moulton AE, Hogan SL, Falk RJ, et al, Glomerular Disease Collaborative Network: Glomerular tip lesion: Clinical features, response to corticosteroids and comparison to focal segmental glomerulosclerosis. J Am Soc Nephrol 8:84A, 1997 (abstr)
16. Beaman M, Howie AJ, Hardwicke J, et al: The glomerular tip lesion: A steroid responsive nephrotic syndrome. Clin Nephrol 27:217-221, 1987
17. Detwiler RK, Falk RJ, Hogan SL, et al: Collapsing glomerulopathy: A clinically and pathologically distinct variant of focal segmental glomerulosclerosis. Kidney Int 45:1416-1424, 1994
18. Valeri A, Barisoni L, Appel GB, et al: Idiopathic collapsing focal segmental glomerulosclerosis: A clinicopathologic study. Kidney Int. 50:1734-1746, 1996
19. Grcevska L, Polenakovik M: Collapsing glomerulopathy: Clinical characteristics and follow-up. Am J Kidney Dis 33:652-657, 1999
20. Schwartz MM, Korbet SM, Rydell J, et al: Primary focal segmental glomerular sclerosis in adults: Prognostic value of histologic variants. Am J Kidney Dis 25:845-852, 1995
21. Schwartz MM, Evans J, Bain R, et al: Focal segmental glomerulosclerosis: Prognostic implications of the cellular lesion. J Am Soc Nephrol 10:1900-1907, 1999
22. ten Holder SM, Hogan SL, Nachman PH, et al, Glomerular Disease Collaborative Network: Response to corticosteroids and ACE inhibitors/ACE receptor antagonists in a contemporary cohort of patients with focal segmental glomerulosclerosis. J Am Soc Nephrol 11:99A, 2000 (abstr)
23. Hogan SL, ten Holder S, Nachman PH, et al, Glomerular Disease Collaborative Network: Predictors of outcome in a contemporary cohort of patients with focal segmental glomerulosclerosis. J Am Soc Nephrol 11:87A, 2000 (abstr)
24. Ingulli E, Tejani A: Racial differences in the incidence and renal outcome of idiopathic focal segmental glomerulosclerosis in children. Pediatr Nephrol 5:393-397, 1991
25. Stengel B, Couchoud C, Cenee S, et al: Age, blood pressure and smoking effects on chronic renal failure in primary glomerular nephropathies. Kidney Int 57:2519-2526, 2000
26. Cattran DC, Appel GB, Hebert LA, et al: A randomized trial of cyclosporine in patients with steroid-resistant focal segmental glomerulosclerosis. North America Nephrotic Syndrome Study Group. Kidney Int 56:2220-2226, 1999